We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Balloon Sinuplasty Effective for Treating Chronic Sinusitis

By HospiMedica International staff writers
Posted on 13 Oct 2008
Follow-up studies of balloon sinuplasty patients confirm that sinuplasty technology is safe and effective when used to treat chronic sinusitis patients. More...


Researchers at the Georgia Nasal and Sinus Institute (Savannah, USA) and the Sinus Center of the South (Biloxi, MS, USA) conducted one and two year follow-ups of 109 patients who had minimally invasive sinus surgery using balloon sinuplasty technology that were performed in 2005; all patients had participated previously in the Clinical Evaluation to Confirm Safety and Efficacy of Sinuplasty in the Paranasal Sinuses (CLEAR) study. Patients were prospectively evaluated by Sinonasal Outcome Test (SNOT-20) and computed tomographic (CT) scan. The studies found that 92% of the patients had functional patency of the cleared drainage channels at one-year follow-up; at two-year follow-up, 85% of patients reported improvement in their sinus symptoms. No patient's condition worsened, and clinically and statistically significant improvements in their quality of life were maintained at one and two year follow-up. No serious adverse events observed at any time point throughout the studies. Both studies were published in the September 2008 issue of Otolaryngology - Head and Neck Surgery.

"These multi-year data continue to affirm the safety and effectiveness of balloon sinuplasty technology. Patients can feel confident that this technology truly provides significant, durable improvement in sinus symptoms and overall quality of life,” said lead author of the two-year study and co-author of the one-year study, otolaryngologist Raymond Weiss, M.D. of the Sinus Center of the South.

Balloon Sinuplasty technology, developed by Acclarent (Menlo Park, CA, USA) is used to restore normal sinus drainage by widening constricted passages with balloons using an endoscopic, catheter-based system, and can be used alone or in conjunction with standard surgical instrumentation. There is little or no damage to nasal mucosa or to the ostia of the sinus. Recovery times vary after sinus surgery, but patients typically return to normal activities within 24 hours of treatment.

Related Links:
Sinus Center of the South
Acclarent


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.